By Stuart O. Schweitzer. 246 pp. New York, Oxford University Press, 1997. $39.95. ISBN 0-19-510524-9.
A few years ago, a book on pharmaceutical economics and policywould probably have been greeted with murmurs of polite interestfrom a few select areas of the health care community and thenhave been consigned to use as a reference by these sectors.The increasing importance of managed care, concern about therate of increase in pharmaceutical prices, questions about alag in the timing of new drug approvals in the United Statesas compared with Europe, and the increasing globalization ofthe U.S. economy have all served to focus attention on the pharmaceuticalindustry and its importance throughout . . . [Full Text of this Article]
Previous
